BDBM37585 MLS000117493::N-[2-(1-cyclohexenyl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxo-3-quinolinecarboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-keto-quinoline-3-carboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxidanylidene-quinoline-3-carboxamide::N-[2-(cyclohexen-1-yl)ethyl]-6-(dimethylsulfamoyl)-1-ethyl-4-oxoquinoline-3-carboxamide::SMR000094441::cid_5307635
SMILES CCn1cc(C(=O)NCCC2=CCCCC2)c(=O)c2cc(ccc12)S(=O)(=O)N(C)C
InChI Key InChIKey=HJTABMAEVMBUTK-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37585
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair